Chikungunya is a mosquito borne viral disease caused by the RNA virus belonging to the alphavirus genus of family Togaviridae. Chikungunya fever has been reported in more than 60 countries of Asia, Africa, Europe and the Americas. Its transmission from human to human is facilitated by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. The Chikungunya Fever Market is expected to grow at CAGR 5.86% during forecast period.
Chikungunya Fever Market – Segmentation
The Chikungunya Fever Market is segmented on the basis of diagnosis, treatment, and end users.
On the basis of diagnosis, the market is segmented into ELISA based assays, serological tests, virological tests, and others. ELISA based assays is futhur segmented into IgM based ELISA and IgG ELISA. On the basis of treatment, the market is segmented into allopathy, homeopathy, Ayurveda, and others.
The allopathy segmented is sub segmented into anti-pyretics, optimal analgesics, and others. The homeopathy segment is sub segmented into pyroginum, rhus-tox, cedron, and others. The ayurveda segment is sub segmented into amrutharista, mahasudarshana churna, dhanvantaram gutika and others. On the basis of end users, the market is segmented into hospitals and clinics, academic institutes, research laboratories, and others.
Chikungunya Fever Market – Key Players
The key players for the chikungunya market are Quest Diagnostics Incorporated. (U.S.A), Alere. (U.S.A), Genome Diagnostics Pvt. Ltd. (India), altona Diagnostics (Europe), Bio-Rad Laboratories, Inc. (U.S.A), Sanat Products Ltd. (India), Taj Pharmaceuticals Limited. (India), and Etubics Corporation (U.S.A).
Chikungunya Fever Market – Intended Audience
- Pharmaceutical companies
- Biotechnological institutes
- Government and Private Laboratories
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Market Research and Consulting Service Providers
Chikungunya Fever Market – Overview
Currently, there is no cure for the disease and the treatments are focused only to relieve the symptoms. In 2016, according to the World Health Organization, 349 936 suspected and 146 914 laboratory confirmed cases of chikungunya were reported to the PAHO regional office. Countries that reported the most cases were Brazil (265 000 suspected cases), Bolivia and Colombia (19 000 suspected cases, respectively).
Increasing per capita healthcare expenditures, rising R&D investments by the market players, and growing geriatric population are the major factors that will drive the market growth during the forecasted period. Moreover, pouring government investments and favourable policies will fuel the market. However, factors such as lack of awareness and cost of treatment and diagnosis can restrain the market growth during the forecasted period.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4694 .
Moreover, ayurveda and homeopathy can be employed in the treatment procedures. According to the World Health Organization, the disease mostly occurs in Africa, Asia and the Indian subcontinent. However a major outbreak in 2015 affected several countries of the region of the Americas. This is expected to boost the market growth across the globe during the forecasted period.
Chikungunya Fever Market – Regional Analysis
The Americas dominate the global chikungunya fever market owing to a large patient population, strong government support for research & development, and high healthcare spending. Moreover, presence of the global market leaders within the regions facilitates the market growth within the region during the forecasted period.
Europe has the second leading market in global chikungunya fever market which is followed by Asia Pacific. Asia Pacific is the fastest growing market for chikungunya fever. On 22 September 2017, according to the European Centre for Disease Prevention and Control there were about 102 autochthonous chikungunya cases in Italy. Moreover, similar cases were reported in France. Such factors in the presence of a well-developed healthcare infrastructure along with high per capita healthcare expenditures made Europe to generate high revenues for the global chikungunya fever market. Asia Pacific chikungunya fever market is majorly driven by Indian and China owing to a huge patient pool, and continuously developing healthcare sector have fuelled the growth of the market.
The Middle East and Africa contribute the least in the growth of global chikungunya fever market. The Middle East dominates the market for The Middle East and Africa. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East market. Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition. However the growth of the Africa market is high due to the presence of opportunities for the development of the market.
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/4694 .
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
List of Tables
Table 1 Chikungunya Fever Industry Synopsis, 2017 – 2023
Table 2 Global Chikungunya Fever Market Estimates and Forecast, 2017 – 2023, (USD Million)
Table 3 Global Chikungunya Fever Market by Region, 2017 – 2023, (USD Million)
List of Figures
Figure 1 Research Process
Figure 2 Segmentation for Global Chikungunya Fever Market
Figure 3 Segmentation Market Dynamics for Global Chikungunya Fever Market
Continued….
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com
Your information will never be shared with any third party.